Skip to main content


Diffuse Large B-Cell Lymphoma

Featured

Quiz
True or False: For patients with DLBCL, health care resource utilization and costs are greater for hematopoietic cell transplant compared with CAR-T therapy.
News
The rate of surveillance imaging of survivors of DLBCL decreased after the American Society of Hematology (ASH)…
Videos
Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation…
Conference Coverage
HCRU and costs associated with CAR-T therapy were greater than transplantation for DLBCL and cost offsets before and…
Conference Coverage
Study results show polatuzumab vedotin plus bendamustine-rituximab is cost-effective in comparison to bendamustine-…
Back to Top